Genetic screen for monitoring hepatitis C virus NS3 serine protease activity

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 5, 2003, Pages 1760-1765

  Martinez, Miguel Angel ^a   Clotet, Bonaventura ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PLASMID VECTOR; SERINE PROTEINASE; VIRUS ENZYME;

ANIMAL CELL; ARTICLE; BACTERIOPHAGE LAMBDA; ENZYME ACTIVITY; ESCHERICHIA COLI; GENETIC SCREENING; HEPATITIS C; HEPATITIS C VIRUS; LYSOGENIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRESSOR GENE;

AMINO ACID SEQUENCE; BACTERIOPHAGE LAMBDA; ESCHERICHIA COLI; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0038673317     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.5.1760-1765.2003     Document Type: Article

References (31)

1. Alter, H. J. 1995. To C or not to C: these are the questions. Blood 85:1681-1695.
2. Cabana, M., G. Fernandez, M. Parera, B. Clotet, and M. A. Martinez. 2002. Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions. Virology 300:71-78.
3. Carpenter, C. C., D. A. Cooper, M. A. Fischl, J. M. Gatell, B. G. Gazzard, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. Montaner, D. D. Richman, M. S. Saag, M. Schechter, R. T. Schooley, M. A. Thompson, S. Vella, P. G. Yeni, and P. A. Volberding. 2000. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 283:381-390.
4. Choo, Q. L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, R. Medina-Selby, P. J. Barr, et al. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455.
5. Dimasi, N., A. Pasquo, F. Martin, S. Di Marco, C. Steinkuhler, R. Cortese, and M. Sollazzo. 1998. Engineering, characterization and phage display of hepatitis C virus NS3 protease and NS4A cofactor peptide as a single-chain protein. Protein Eng. 11:1257-1265.
6. Dunn, B. M. (ed.) 1999. Proteases of infectious agents. Academic Press, San Diego, Calif.
7. Filocamo, G., L. Pacini, and G. Migliaccio. 1997. Chimeric Sindbis viruses dependent on the NS3 protease of hepatitis C virus. J. Virol. 71:1417-1427.
8. Gulick, R. M., J. W. Mellors, D. Havlir, J. J. Eron, C. Gonzalez, D. McMahon, D. D. Richman, F. T. Valentine, L. Jonas, A. Meibohm, E. A. Emini, and J. A. Chodakewitz. 1997. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337:734-739.
9. Hammer, S. M., K. E. Squires, M. D. Hughes, J. M. Grimes, L. M. Demeter, J. S. Currier, J. J. Eron, Jr., J. E. Feinberg, H. H. Balfour, Jr., L. R. Deyton, J. A. Chodakewitz, M. A. Fischl, et al. 1997. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 337:725-733.
10. Hijikata, M., H. Mizushima, T. Akagi, S. Mori, N. Kakiuchi, N. Kato, T. Tanaka, K. Kimura, and K. Shimotohno. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. 67:4665-4675.
11. Hirowatari, Y., M. Hijikata, and K. Shimotohno. 1995. A novel method for analysis of viral proteinase activity encoded by hepatitis C virus in cultured cells. Anal. Biochem. 225:113-120.
12. Kim, J. L., K. A. Morgenstern, C. Lin, T. Fox, M. D. Dwyer, J. A. Landro, S. P. Chambers, W. Markland, C. A. Lepre, E. T. O'Malley, S. L. Harbeson, C. M. Rice, M. A. Murcko, P. R. Caron, and J. A. Thomson. 1996. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87:343-355.
13. Kim, S. Y., K. W. Park, Y. J. Lee, S. H. Back, J. H. Goo, O. K. Park, S. K. Jang, and W. J. Park. 2000. In vivo determination of substrate specificity of hepatitis C virus NS3 protease: genetic assay for site-specific proteolysis. Anal. Biochem. 284:42-48.
14. Kwong, A. D., J. L. Kim, G. Rao, D. Lipovsek, and S. A. Raybuck. 1998. Hepatitis C virus NS3/4A protease. Antivir. Res. 40:1-18.
15. Lohmann, V., F. Korner, J. Koch, U. Herian, L. Theilmann, and R. Bartenschlager. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113.
16. Mak, P., O. Palant, P. Labonte, and S. Plotch. 2001. Reconstitution of hepatitis C virus protease activities in yeast. FEBS Lett. 503:13-18.
17. Martinez, M. A., M. Cabana, M. Parera, A. Gutierrez, J. A. Este, and B. Clotet. 2000. A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type 1 protease. Antimicrob. Agents Chemother. 44:1132-1139.
18. Martinez, M. A., V. Pezo, P. Marliere, and S. Wain-Hobson. 1996. Exploring the functional robustness of an enzyme by in vitro evolution. EMBO J. 15:1203-1210.
19. Martinez, M. A., J. P. Vartanian, and S. Wain-Hobson. 1994. Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc. Natl. Acad. Sci. USA 91:11787-11791.
20. Pessi, A. 2001. A personal account of the role of peptide research in drug discovery: the case of hepatitis C. J. Peptide Sci. 7:2-14.
21. Ptashne, M. 1986. A genetic switch. Cell Press, Cambridge, Mass.
22. Reed, K. E., A. Grakoui, and C. M. Rice. 1995. Hepatitis C virus-encoded NS2-3 protease: cleavage site mutagenesis and requirements for bimolecular cleavage. J. Virol. 69:4127-4136.
23. Rosenberg, S. 2001. Recent advances in the molecular biology of hepatitis C virus. J. Mol. Biol. 313:451-464.
24. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
25. Shimizu, Y., K. Yamaji, Y. Masuho, T. Yokota, H. Inoue, K. Sudo, S. Satoh, and K. Shimotohno. 1996. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J. Virol. 70:127-132.
26. Sices, H. J., and T. M. Kristie. 1998. A genetic screen for the isolation and characterization of site-specific proteases. Proc. Natl. Acad. Sci. USA 95:2828-2833.
27. Sices, H. J., M. D. Leusink, A. Pacheco, and T. M. Kristie. 2001. Rapid genetic selection of inhibitor-resistant protease mutants: clinically relevant and novel mutants of the HIV protease. AIDS Res. Hum. Retrovir. 17:1249-1255.
28. Taremi, S. S., B. Beyer, M. Maher, N. Yao, W. Prosise, P. C. Weber, and B. A. Malcolm. 1998. Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease. Protein Sci. 7:2143-2149.
29. Tomei, L., C. Failla, E. Santolini, R. De Francesco, and N. La Monica. 1993. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67:4017-4026.
30. Tomei, L., C. Failla, R. L. Vitale, E. Bianchi, and R. De Francesco. 1996. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. J. Gen. Virol. 77:1065-1070.
31. Urbani, A., G. Biasiol, M. Brunetti, C. Volpari, S. Di Marco, M. Sollazzo, S. Orru, F. D. Piaz, A. Casbarra, P. Pucci, C. Nardi, P. Gallinari, R. De Francesco, and C. Steinkuhler. 1999. Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide. Biochemistry 38:5206-5215.